High-protein, high-fiber, hydration and electrolyte, and gut health products rank as the top categories of interest, especially among Gen Z and Millennial users
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonista class of medications that mimic your body's natural GLP-1 hormone
We do not knowingly solicit or collect personal information from children under the age of 13 without parental consent
However, we also recognize that the most successful weight loss outcomes come from comprehensive weight loss programs that address the factors standard prescribers often miss
Lilly has signaled that detailed results will be presented at the American Diabetes Association Scientific Sessions in June 2026, with multiple additional Phase 3 readouts (TRIUMPH-2, TRIUMPH-3, and the cardiovascular outcomes trial) expected later in 2026 [1][10]
Medications Semaglutide, known by the brand name Wegovy, and liraglutide (Saxenda) have been specifically approved for weight loss in obesity, in combination with lifestyle changes